Trial Profile
Multicenter Uveitis Steroid Treatment (MUST) Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jan 2021
Price :
$35
*
At a glance
- Drugs Fluocinolone acetonide (Primary)
- Indications Uveitis
- Focus Therapeutic Use
- Acronyms MUST
- 25 Nov 2015 New source identified and integrated (Current Controlled Trials : ISRCTN15396562)
- 25 Nov 2015 New trial record